CareTria, backed by Frazier Healthcare Partners, has acquired CaryHealth, a Washington, DC-based AI-powered digital pharmacy. The deal combines CaryHealth’s AI-driven digital automation with CareTria’s pharmacy fulfillment infrastructure to create an industry-leading pharmacy partner for biopharma companies. Areo Nazari, CaryHealth’s CEO, emphasized the strategic synergy, stating the merger enhances CareTria’s ability to streamline therapy initiation for pharmaceutical firms.

CaryHealth, founded in 2017, specializes in AI-driven solutions for medication access and patient engagement. CareTria, a therapy initiation partner to pharmaceutical companies, leverages its fulfillment network to reduce delays in patient treatment. The acquisition signals a push by Frazier Healthcare to expand its footprint in digital health infrastructure, though financial terms remain undisclosed.

The move reflects growing consolidation in the digital pharmacy sector, where AI and automation are reshaping how biopharma firms manage drug distribution. By integrating CaryHealth’s technology, CareTria aims to address inefficiencies in clinical trial logistics and patient adherence. This aligns with broader trends in healthcare tech, where partnerships between traditional pharma and digital innovators are accelerating.

Key entities: Companies: CareTria, CaryHealth, Frazier Healthcare Partners; People: Areo Nazari; Locations: Washington, DC. Primary keyword: "CareTria Acquires CaryHealth". Secondary keywords: digital pharmacy, AI-driven automation, biopharma partnerships, therapy initiation. Content type: news.